Search

Your search keyword '"Waserman S"' showing total 368 results

Search Constraints

Start Over You searched for: Author "Waserman S" Remove constraint Author: "Waserman S"
368 results on '"Waserman S"'

Search Results

1. Food allergy and anaphylaxis

6. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

7. LEUKOTRIENE RECEPTOR ANTAGONISTS WITH ANTIHISTAMINES VERSUS ANTIHISTAMINES ALONE FOR CHRONIC URTICARIA: SYSTEMATIC REVIEW AND META-ANALYSIS

9. Building and implementing best practices for referral and management of severe asthma in Canadian healthcare

10. Refractory Anaphylaxis: A New Entity for Severe Anaphylaxis

12. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

13. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

14. Development and validation of combined symptom-medication scores for allergic rhinitis*

15. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model

16. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update – I – Plan and definitions

17. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update – XIV – Recommendations on CMA immunotherapy

18. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world data

19. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

20. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

21. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

22. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

25. Management of anaphylaxis due to COVID-19 vaccines in the elderly

26. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach

27. Prevention and management of allergic reactions to food in child care centers and schools: Practice guidelines

28. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

29. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

30. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

31. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

32. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

33. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

34. Treatment of allergic rhinitis during and outside the pollen season using mobile technology : A MASK study

35. Managing Food Allergy in Schools During the COVID-19 Pandemic

40. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

41. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

42. ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

43. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

44. 2019 ARIA Care pathways for allergen immunotherapy

45. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

46. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

47. Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks

48. 2019 ARIA Care pathways for allergen immunotherapy [ARIA-Versorgungspfade für die Allergenimmuntherapie 2019]

49. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases

50. 2019 ARIA Care pathways for allergen immunotherapy

Catalog

Books, media, physical & digital resources